Gamma Knife radiosurgery very early in trigeminal neuralgia, a facial pain condition
Tests Gamma Knife radiosurgery given very early to adults with trigeminal neuralgia.
Key facts
- Who runs it
- University of Alberta
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Ultra-Early Gamma Knife Stereotactic Radiosurgery for TN
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 80 people, planned
- Started
- 30 Jul 2025
- Expected to end
- 1 May 2032
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- GK SRS
- Record updated
- 23 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults diagnosed with classical or idiopathic trigeminal neuralgia (facial nerve pain) in the last 2 years. It compares early Gamma Knife radiosurgery with usual medicine treatment.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Classical or idiopathic trigeminal neuralgia, diagnosed from clinical history and MRI scan within 2 years before joining. Pain must not be resistant to medicines (adequate pain control despite 2 or more medicine trials).
- Earlier treatment
- People cannot join if they had surgery for trigeminal neuralgia or radiation to the head or neck. If taking medicine now, the dose must have been stable for at least 3 months.
Main reasons for not taking part
- Trigeminal neuralgia caused by another condition (secondary), or pain on both sides of the face
- Any reason they cannot have Gamma Knife radiosurgery
- Past radiation to the head or neck, or past surgery for trigeminal neuralgia
- A psychiatric diagnosis within 2 years, or uncontrolled mental illness
- Pregnant or breast-feeding women
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age ≥18 years
- Clinical diagnosis of classical or idiopathic TN, based on clinical history and MRI scan
- Clinical diagnosis within 2 years prior to enrolment
- Not deemed medically refractory (defined as adequate pain control despite ≥2 medication trials of adequate dose. Adequate pain control is defined as pain that is considered acceptably controlled by both the patient and treating neurologist, without the need for further dose escalation)
- If currently on medication, on stable dose x at least 3 months
Who cannot take part
- Any prior surgical intervention for TN
- History of psychiatric diagnoses within 2 years of study participation, or uncontrolled, concurrent psychiatric illness (e.g., depression with recent suicide attempts)
- Any history of head and/or neck radiation therapy
- Secondary TN
- Bilateral TN
- Any contraindications to undergoing GK-SRS
- Females who are pregnant or breast-feeding
This trial is currently available in Canada.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate Gamma Knife stereotactic radiosurgery (GK-SRS) as an ultra-early treatment option for trigeminal neuralgia (TN).
Read full original descriptionShow less
The main questions it aims to answer are:
1. will earlier GK-SRS provide more durable pain relief compared to later GK-SRS? 2. will earlier GK-SRS reduce or eliminate the need for high-dose medical therapy? 3. will earlier GK-SRS have a lower risk of serious complications compared to other first-line treatments?
If participants are assigned to GK-SRS treatment group, they will be asked to:
• Undergo a preoperative MRI, measurements of heart rate and blood pressure, stereotactic head-frame placement, post-operative management and observation.
Both groups will be asked to:
* Complete medical histories and neurological examinations. These are part of standard of care. * Participants will be asked a series of questions related to overall physical health, pain severity, and mood. Completing these questionnaires is part of the research activity. It will take approximately 15- 30 minutes to complete. These questionnaires include: The Barrow Neurological Institute Pain Intensity Score, Brief Pain Inventory-Facial (BPI-Facial), Visual Analog Scale (VAS), Medication Quantification Scale (MQS), Hospital Anxiety and Depression Scale (HADS), Pain Catastrophizing Scale (PCS), and the Short Form Health Survey.
The 2 groups in the trial
- Standard armNo study treatment, for comparison
Patients allocated to the standard arm will continue their medical management per the judgment of treating physician.
- Gamma Knife stereotactic radiosurgery for TNTreatment being tested
Treatment: GK SRS
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Ultra-early Gamma Knife Stereotactic Radiosurgery for Trigeminal Neuralgia
- Plain-language title
- Gamma Knife radiosurgery very early in trigeminal neuralgia, a facial pain conditionGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- Record updated
- 23 October 2026